Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase

Details for Australian Patent Application No. 2008325288 (hide)

Owner AstraZeneca AB

Inventors Ainge, Debra; Munck Af Rosenschold, Magnus; Lundkvist, Michael; Lindsjo, Martin; Chapman, David; Pavey, John; Lonn, Hans; Nikitidis, Antonios

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008325288

PCT Pub. Number WO2009/061271

Priority 60/985,713 06.11.07 US

Filing date 5 November 2008

Wipo publication date 14 May 2009

Acceptance publication date 22 December 2011

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/497 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/061271 Priority application(s): WO2009/061271

22 December 2011 Application Accepted

  Published as AU-B-2008325288

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008325290-Dry powder formulations comprising ascorbic acid derivates

2008325272-Comparative tire animation